NeuralCipher Source record
Phosphorylated alpha-synuclein skin biopsy alters diagnosis in two out of three patients: Initial findings in a tertiary center.
DOI: 10.1016/j.parkreldis.2026.108234PMID: 41691977
A bibliographic record traceable to Europe PMC.
715 articles found
“Parkinson alpha synuclein” Clear search
Source record
D-ribose-L-cysteine and lauric acid co-treatment confers multi-pathway neuroprotection in an alpha-synuclein transgenic Drosophila model of Parkinson's disease.
DOI: 10.1007/s11011-026-01795-yPMID: 41636876
A bibliographic record traceable to Europe PMC.
Source record
Simultaneous inhibition of mTOR and STING as an approach to reduce alpha-synuclein and lysosphingolipid levels in peripheral blood monocytederived macrophages and the SH-SY5Y cell line: implications for therapy of Parkinson's disease.
DOI: 10.18097/pbmcr1616PMID: 41841711
A bibliographic record traceable to Europe PMC.
Open access
Faster reaction times of CSF alpha-synuclein seed amplification assay predict the diffuse malignant subtype of Parkinson's disease at 10-year follow-up.
DOI: 10.1177/1877718x261417468PMID: 41610263
A bibliographic record traceable to Europe PMC.
Open access
Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay.
DOI: 10.1002/mds.70197PMID: 41603617
A bibliographic record traceable to Europe PMC.
Open access
Inhibition of de novo ceramide synthesis mitigates alpha-synuclein pathology in a Parkinson's disease mouse model.
DOI: 10.1038/s41531-026-01263-5PMID: 41559062
A bibliographic record traceable to Europe PMC.
Source record
Novel Therapeutic Strategies in Targeting Alpha Synuclein Dysfunction Pathways for Parkinson's Disease Treatment.
DOI: 10.2174/0118723128397400250910222116PMID: 42841465
A bibliographic record traceable to Europe PMC.
Open access
Revisiting the alpha-synuclein paradox in melanoma-Parkinson's disease connection: more than a tale of two cell fates.
DOI: 10.1007/s00018-025-05985-2PMID: 41460324
A bibliographic record traceable to Europe PMC.
Open access
Correction: MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson's HLA locus exhibits epigenetic regulation.
DOI: 10.1038/s41598-025-31393-4PMID: 41466060
A bibliographic record traceable to Europe PMC.
Source record
Enteric glia, neuropeptides, and Parkinson's: impacts of calcitonin gene-related peptide on gut alpha synuclein.
DOI: 10.1152/ajpgi.00230.2025PMID: 41401974
A bibliographic record traceable to Europe PMC.
Open access
Lack of functional STING modulates immunity but does not protect dopaminergic neurons in the alpha-synuclein pre-formed fibrils Parkinson's disease mouse model.
DOI: 10.1038/s41531-025-01228-0PMID: 41381624
A bibliographic record traceable to Europe PMC.
Source record
Novel PREP ligand, HUP-46, ameliorates behavioral deficits in an alpha-synuclein based Parkinson's disease model.
DOI: 10.1016/j.expneurol.2025.115593PMID: 41386343
A bibliographic record traceable to Europe PMC.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.